
Sign up to save your podcasts
Or


In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577
By American Academy of Neurology4.8
132132 ratings
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention.
Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577

317 Listeners

497 Listeners

299 Listeners

50 Listeners

297 Listeners

3,348 Listeners

12 Listeners

1,148 Listeners

23 Listeners

194 Listeners

92 Listeners

515 Listeners

368 Listeners

188 Listeners

81 Listeners